Multiple enzyme systems produce RONS and their derivatives in the vascular system, including cyclo-oxigenase, lipoxigenase, P450 cytochrome, xanthine oxidase (XO), myeloperoxidase (MPO), nitric oxide synthase (NOS) and NADPH oxidase -this latter one of the most important sources of this substance, both in endothelial cells as in smooth muscle cells .
Multiple enzyme systems produce RONS and their derivatives in the vascular system, including cyclo-oxigenase, lipoxigenase, P450 cytochrome, xanthine oxidase (XO), myeloperoxidase (MPO), nitric oxide synthase (NOS) and NADPH oxidase -this latter one of the most important sources of this substance, both in endothelial cells as in smooth muscle cells .
Since the findings of Baehner et al 23 40 years ago -which allowed the discovery of NADPH oxidase 24 -several studies addressed the relation between said enzyme complex and the redox unbalance (oxidative stress). Increase in production of superoxide anion (
• O 2 -) and other RONS is implied in arteriosclerosis, arterial high blood pressure, cell proliferation and hypertrophy. However, the role of NADPH oxidase in such processes remain unknown, which is mainly attributable to occurrence of multiple isoforms of Nox (subunits which form the NADPH oxidase) and their vehicles, as well as to the lack of specific inhibitors 25, 26 . The enzyme complex act as electron donor for reduction of O 2 into
• O 2 -, following the reaction 2O 2 + NAD(P)H è 2O 2 -+ NAD(P) + H +10, 16, 22, 25, 27 .
• O 2 -: production by NADPH oxidase and its relation with the • 
NO
Groundbreaking experiments of Furchgott and Zawadzki 28 first demonstrated the existence of endothelium-derived relaxing factor which was subsequently identified as • NO 29 , produced based on L-arginine by the action of endothelial nitric oxide synthase (eNOS) [29] [30] [31] [32] in the presence of cofactors, mainly the tetrahydrobiopterin (H 4 B; Figure 1 ). The • NO diffuses into vascular smooth muscle cells and activates the guanylate cyclase, promoting cyclic GMP mediated vasodilation [29] [30] [31] [32] [33] . In normal conditions, the • NO performs key role in maintenance of vascular wall in quiescent status by inhibition of inflammation, cell proliferation and thrombus, reducing vascular tone, activation of platelet and leukocytes, proliferation of smooth muscle cells, extracellular matrix deposition and death of endothelial cells [34] [35] [36] .
• NO is also a free radical and, when produced jointly with
• O 2 -, react in an extremely swift way to form a highly reactive proinflammatory species: the peroxynitrite anion ( . This last substance is an important lipid peroxidation mediator, including LDL oxidation, event of capital importance to atherogenesis 5 .
Physiologically, a certain amount of intracellular
• O 2 -is required for normal signaling performed by • NO. Nevertheless, pathologically, the extracellular increase of the first species
Abstract
Several studies refer to reactive oxygen and nitrogen species (RONS) as important agents in the pathogenesis of a number of heart diseases, including high blood pressure, arteriosclerosis and heart failure. Such species are highly bioactive molecules and a short life due chiefly to reduction of molecular oxygen. The enzyme complex of NADPH oxidase is the main source of these reactive species in vascular system. Under physiological conditions, formation and elimination of these substances seem balanced in vascular wall. During redox Unbalance, nonetheless, there is increase in NADPH oxidase activity and predominance of pro-oxidizing agents, surpassing the anti-oxidant capacity of the organism self-defense. Besides this, such enzyme hyperactivity reduces the bioavailability of nitric oxide, capital for vasodilation and maintenance of normal vascular function. In spite of NADPH oxidase being directly connected to the endothelial dysfunction, it was firstly described as for its expression in phagocytes, where its activity determines efficiency of organism defense mechanisms against pathogens. Slight differences between structural units
Introduction
Several studies show that reactive oxygen and nitrogen species (RONS) effectively contribute to pathogenesis of cardiovascular disorders, such as high blood pressure, arteriosclerosis, hypertrophy and heart failure and restenosis, in addition to lesions arising out ischemia and reperfusion. decreases the bioavailability of • NO, reducing its diffusion into the vascular smooth muscle 38, 39 . In certain circumstances, chronic production of RONS (increase in the NADPH oxidase activity, for instance) exceeds the capacity of cell enzymatic antioxidants (such as the glutathione peroxidase-1 -main oxidant enzyme in cytosol and in mitochondria 35, 36 -and the forms of superoxide dismutase linked to the membrane, responsible for dismuting the superoxide anion into H 2 O 2 ) and cell non-enzymatic antioxidants, contributing to vascular disease due to sustained endothelial activation 29, 40 . Large amounts of -generated may also be transformed into hydroxyl radical, which diffuses into the vascular smooth muscle and induces the production of vasoconstrictive endoperoxides, such as prostaglandin H 2 and prostanoids 41 , derived from the peroxidation of the arachidonic acid catalyzed by free radical, considered as indicators of systemic increase of redox unbalance in vivo 42 .
The excess of
• O 2 -production, with subsequent decrease of • NO's bioavailability, may be also caused by transition metals, such as iron, copper, mercury and lead. Some of these environment pollutants are capable of increasing the production of free radicals by means of activation of enzyme complex NADPH oxidase 43, 44 , and this mechanism may be seen as probable cause of high blood pressure induced by said chemical species.
Studies by Wiggers et al 45 showed that the exposure of rats to low concentrations of mercury induces endothelial dysfunction both in conductance and resistance vessels. Authors imply this event is likely arisen out of reduction of • NO's bioavailability due to the increase of vascular production of
-. Thus, it is possible that treatment with mercury affect the protein expression or, more specifically, the activity of NADPH oxidase.
Such unbalance is related to RONS due to the fact that the O 2 is germane to cell respiration, and there are several enzyme systems which use this substrate as an electron acceptor 1, 20 . Family of such species includes highly bioactive molecules with short life due chiefly to O 2 reduction. Physiologically, the formation and elimination of RONS are balanced in the vascular wall 46 , whose key role is played by the endothelium in maintenance of vascular tone and in blood pressure by releasing vasoactive substances, such as the • NO 47 . The increase of RONS due to redox unbalance was found in elder rats' and mice's aorta, carotid, mesenteric and coronaries, implying that this unbalance is associated to ageing, with the increase of NADPH oxidase activity 48 . Experimental evidences indicate that the oxidative damage induced by reactive species derives from the increase of bioavailability. However, in spite of the excess of RONS being toxic, physiological concentrations of these species may function as mediator signs of several responses, including cell migration and growth 20, 22, 50 , once, under normal conditions and in most arteries, the production of 
Non-selective inhibition of NADPH oxidase compromises physiological cell signaling
Better categorized NADPH oxidase is the phagocytic, present in macrophages and neutrophils, being a multimeric protein complex with components in cell membrane and cytoplasm. The component associated to the membrane is the cytochrome b558-oxidase, formed by a larger sub-unit, the gp91phox (the term "phox" comes from "phagocytic oxidase") 7 , and a smaller sub-unit, the p22phox. Besides these, the enzyme comprises three cytoplasmatic subunits (p47phox, p67phox e p40phox) and a small regulatory protein G (Rac2). Activation of NADPH oxidase begins with serine phosphorylation of the cytoplasmatic subunit p47phox, triggering its migration to the membrane, where, jointly with Rac, gets associated with the cytochrome b558, beginning the enzyme's catalytic activity 1, 5, 17, 37, [53] [54] [55] [56] [57] [58] ( Figure 2 ).
NADPH oxidase expressed in vascular cells differs from those found in phagocytes, both for its biochemical structure and for its functions 5 . It was initially found in neutrophils, which are well-known as essential defenders against microorganisms released by a combination of several mechanisms, including the generation of
• O 2 -produced by endothelial subunits p40phox, p47phox and gp91phox of the NADPH oxidase 54 . Intriguingly, the catalytic groups gp91phox, p22phox, p47phox and p67phox were also found in adventitial fibroblasts 7, 13, 22, 55 .
Identification of subunits homologous to gp91phox resulted in the formation of Nox family (from "nonphagocytic NADPH oxidase"), currently consisting of seven members (Nox1, Nox2 [formally known as gp91phox], Nox3,Nox4, Nox5, Duox1 and Duox2 [dual oxidase]) 10, 56, 57 . The main components of enzyme complex NADPH oxidase, Nox1 and Nox4, are highly expressed in vascular cells and increased during the vascular remodeling process, such as in high blood pressure and atherosclerosis 7 . These slight differences in structural expression facilitate development of specific inhibitors of the vascular NADPH oxidase which do not compromise the physiological signaling and the phagocytic functions mediated by RONS 5 .
Several characteristics of the NADPH oxidases are striking. First, the vascular enzyme produces
-in low levels and for long periods, mostly intracellularly, where it plays the role of cell signalling 1, 5, 14, 16, 46, 50, 59 ( Figure 3 ). Second, gp91phox is usually substituted for homologous Nox1 or Nox4, particularly in smooth muscles. Third, while the homologous Nox and the subunit p22phox connected to the membrane are capital to maintaining a stable unit which supports the electron transfer for generation of
• O 2 -, the role of cytosolic components in NADPH oxidase remain blurred, whose last aspect has implications on activation and specificities of the inhibitors of said enzyme 1, 5, 14, 16, 46 . Besides this, the expression of subunits seems to vary in smooth muscle cells of different vessels. Human vascular smooth muscle cells (HVSMC) seem to express a subunit gp91phox similar to neutrophillic 60 subunit. The homologous of gp91phox, the Nox1, is expressed in rat vascular smooth muscle cells (RVSMC) and the ones of mice 61 and aortic smooth muscle cells (ASMC), and do not appear in human vascular smooth muscle cells 60 . Nox1 is 56% homologous to human gp91phox and, jointly with p22phox, is the probable functional component of cytochrome b558 in ASMCs and RVSMC 62 . Nox4, another homologous of gp91phox, is expressed in RVSMC, ASMC and HVSMC. Endothelial cells are mainly expressed in subunits Nox2 and Nox4. Expression of Nox1 is less prominent in endothelium and may be increased during leukocyte adhesion process and shearing stress. Nox2 and Nox4 seem to be the most important functional subunits in endothelial cells, contributing similarly in production of reactive species 63 .
There is also evidence that the NADPH oxidase is found in the cell nucleus, acting in the gene expression. Several groups identified subunits of NADPH oxidase in internal membranes. However, consequences of the NADPH oxidase activation in between are not clear as of yet 20 .
Enzyme activation: central role of subunits p47phox and gp91phox
The most relevant beginning event for the activation of NADPH oxidase involves the phosphorylation of p47phox and the consequent interaction with gp91phox 1, 16 . Bond between homologous domains of two structures Src produce self-inhibition of bond with p22phox. Such self-inhibiting interaction is lost in phosphorylation, allowing bond between the subunits p47phox and p22phox 1 , and the activation of NADPH oxidase is made. Confirming this, a gene deletion of subunit gp91phox provides protection against ischemic stroke in mice, as it helps to prevent hematoencephalic barrier dysfunction 64 .
NADPH oxidases are activated and regulated by several factors, as mechanical forces, hormones and cytokines, considering the thrombin, the Platelet-Derived Growth Factor (PDGF), the α Tumor Necrosis Factor (TNF-α), the lactosylceramide, the Interleukin-1 and the oxidized LDL stand out among these factors (Figure 1 ). The last one increases the production of RONS and the expression of Nox4 in human endothelium 1, 5 . Cultivated macrophages accumulate large amounts of cholesterol when exposed to modified LDL (receptors for LDL are abundant in these cells, indicating that such structures would be involved in the formation of artherosclerotic foam cells) 58, 65 .
In vascular smooth muscle cells, the angiotensin II (Ang II) is a potent stimulator of NADPH oxidase activity. This angiotensinergic peptide is a known aspect in pathogenesis of most cardiovascular disorders, and it may induce formation of • O 2 -, partly due to vascular NADPH oxidases 5 . The activation mediated by Ang II was first demonstrated by Griendling et al 66 , underscoring the importance of Ang II concentrations in the increase of NADPH oxidase's activities in vascular smooth muscle cells 1, 15, 16 . Despite the signaling by Ang II stimulating NADPH oxidase is not thoroughly studied, PLD, PKC, PLA2, PI3K and thiol oxireductases pathways seem to be involved [67] [68] [69] . In vascular smooth muscle, Src tyrosine kinase regulates the NADPH oxidase activity stimulated by Ang II, inducing phosphorylation and translocation of subunit p47phox 15 . Besides this, Src is capital for the effects of Ang II in the NADPH's subunits synthesis, stimulating the increase in the expression of gp91phox, p22phox, p47phox and p67phox 60 . In addition to this, phosphorylation of Src precedes the activation of ERK1/2 and JNK cascades in vascular smooth muscle, leading to migration, cell growth, apoptosis and deposition of collagen 70 , activating focal adhesion complexes, and has important participation in vascular inflammatory response 71 . These proliferative and inflammatory pathways provide positive feedback to the activation of NADPH oxidase in the vascular system. In vascular smooth muscle, the EGF receptor transactivation seems to be involved, leading to activation of PI3 kinase and small RacG protein minutes after the receptor AT1 of angiotensin is activated 5, 11, 14, 16, 20, 46, 72, 73 . Ang II acts by increasing the NADPH oxidase subunits' expression in hours or days 5, 11, 14, 15, 46 . In animal models proposed by Rajagopalan et al 11 , the production of vascular
-, the NADPH oxidase activity and the level of expression of p22phox, gp91phox, p67phox and Nox1 have increased (there was 100% for the NADPH oxidase).
In the event of activation by Ang II, the H 2 O 2 , generated from the
-produced by NADPH oxidase, is capital for the hypertrophy of vascular smooth muscle cells 54 , also acting as a vasoconstrictor (Figure 4) . Nonetheless, in certain vascular beds, both in human and mice, endogenous H 2 O 2 , in low concentrations, acts as an endothelium-dependent relaxing factor, promoting peripheral, coronary hyperpolarization and vasodilation, as well as in cerebral arteries 74, 75 . In cultivation of smooth muscle cells, Ang II induces hypertrophy mediated by H 2 O 2 , by means of activation of the expression of protooncogenes, MAP kinase and Akt/PKB 54 . In mice with deficiency in gene which expresses the gp91phox, the Ang II fails to induce cardiac hypertrophy 17 . Besides this, experimental evidences show that the • NO is a chemoattraction factor for angiogenesis, and inhibiting its production blocks vascular neoformation 49 . In addition to this, Ang II also promotes mechanisms involved in inflammatory response, and it may simultaneously stimulate the production of , and biologically active component of renin-angiotensin system 17, 25, 77 . Ang-(1-7) seems to inhibit phosphorylation of Src induced by Ang II 12 , promoting endothelium-dependent vasodilation due to induction of • NO 36 release. As for the humoral activation mechanisms, the aldosterone regulates the MAP kinase and the generation of -by NADPH oxidase through c-Src-dependent mechanisms 72 . Some therapeutic actions of hypotensor drugs (angiotensin receptor blockers and angiotensin converter enzyme inhibitors) are attributed to inhibitors of NADPH oxidase, with consequent reduction in production of RONs 25 . However, there is no record that these therapeutic strategies which have as target such species may bring direct benefit to control of high blood pressure patients 18 .
Cardiovascular and neurodegenerative diseases are related to increased activity of NADPH oxidase
Clinical studies show that RONS play a significant role in high blood pressure. The production of these species undergoes increase in patients suffering from essential high blood pressure, renovascular hypertension, malignant hypertension and preeclampsia hypertension 25 . Besides this, increased production of
-by NADPH oxidase in vessels is related to risk factors for arteriosclerosis (Fig. 1) and harm to endothelial function in coronary heart disease patients 5 .
Production of
• O 2 -appears increased in atheroschlerotic blood vessels 2, 40, 42 , contributing to the beginning of proinflammatory events, with gene transcription regulation of vascular cell adhesion molecules and chemoattractive proteins for monocytes 78 . Patients suffering from arteriosclerosis present both endothelial dysfunction and redox unbalance. However, the accurate association mechanism for these two events in 
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The endothelial dysfunction is related to the increase in the NADPH oxidase activity (by increase of expression of its catalytic subunits 14, 53, 79 ), ever since atherosclerotic lesions in human coronaries show strong expression of gp91phox in the vulnerable area of the plaque. Besides this, Nox4 increases during the stage of formation of atheroma, whose appearance happens in a reduced form in advanced lesions. Great saphenous veins and internal mammary arteries of patients with diabetes mellitus present an increase in the NADPH oxidase activity and in decoupled eNOS (in this status, the enzyme acts as producer of Vitamin supplementing may reduce vascular redox unbalance and improve total oxidative status. For instance, some animal models in which antioxidant properties of vitamins C and E are associated to decrease in activation of NADPH oxidase 42, 80 and increase in SOD activity (the largest system of cellular defense against
). It may be advocated that hydrophobic vitamin E could inhibit the formation of enzyme complex of the NADPH oxidase subunits 49 . Despite these observations, clinical tests with antioxidant vitamins have not shown therapeutic benefits as for mortality in cardiovascular events 25, 46 . Besides this, depending mainly on the posology, such substances may present prooxidant properties with harmful organic interactions. As the data from major prospective clinical studies has failed to demonstrate beneficial effects of antioxidants 25 , a balanced diet without vitamin supplementing is commonly recommended, ever since potential harms of supplementing are still undefined.
In high blood pressure, the product of the activation of NADPH oxidase, the
• O 2 -, produces the oxidation of H 4 B, leading to an increase in the eNOS decoupling, and the levels of this type of oxygen increase, causing the bioavailability of • NO 14 to drop. Thus, H 4 B is believed to be deficient in condition associated with altered endothelial function, such as hypercholesterolemia, diabetes, high blood pressure and tobacco addiction. Stroes et al 81 showed that the treatment with H 4 B increase vasodilation in human with hypercholesterolemia, insofar the removal of this biopterine implies in eNOS 40 decoupling. In support to these findings, the eNOS superexpression prevents hypoxia-induced pulmonary vascular remodeling 52 , causing structural changes and alterations in cellular processes that result in increase of the median layer: vascular lumen ratio 82, 83 .
Another factor implied in the redox unbalance is the endotoxemia. During its progress, release of lipopolysaccharides promotes increase of expression and activity of xanthine oxidase and of NADPH oxidase 46 . The increase of NADPH oxidase-dependent RONS in endosomes is important to pro-inflammatory immune response 20 . Activated neutrophils produce • NO-donor drugs (nitrodilators) have been used to treat coronary heart diseases, high blood pressure and heart failure, having anti-inflammatory actions on vascular wall as suppressors of lipoprotein oxidation, inhibitors of migration and proliferation of vascular smooth muscle cells and platelet aggregation inhibitors. They act as suppressors of the expression of adhesion molecules and chemiokines after the stimulation with proinflammatory factors. Such aspects prevent the inflammatory cell infiltration into the vascular wall, where there is also opposition to pro-inflammatory actions of RONS. In addition to this, it was recently found that
• NO seems to have anti-inflammatory effect of artery wall due to its suppression of RONS generator enzymes, particularly the NADPH oxidase 5 .
Nox proteins are also related to other countless organic disorders, including cancer, bone reabsorption and Alzheimer Disease, as they are expressed in several tissues 1, 80, 86 . Evidences demonstrate the role of Nox2 in neurodegenerative processes, such as Parkinson's disease, stroke, cerebral trauma and meningitis, mainly due to neurotoxicity of RONS 57, 87 . Thus, the Nox inhibitors present significant clinical potential, particularly if they do not inhibit the activity of phagocytes 1 .
Inhibitors of NADPH oxidase: potential therapeutic target
Pharmacological inhibitors of NADPH oxidase which block directly the activity of this enzyme have been described as consisting of peptide and non-peptide structures. The DIP-diphenyleneiodonium 5,10 and 4'-hydroxy-3-methoxyacetophenone (the apocynin, isolated from the medicinal plant Picrorhiza kurroa) 88 has been broadly used to block the activity of the NADPH oxidase in vitro 5 . Currently, the DPI-diphenyleneiodonium is known to be non-selective and act as non-specific oxidant 6 . In its turn, the apocynin has multiple biological actions in addition to antioxidant effects 5 , being characterized as an inhibitor of NADPH oxidase since the 80's 6 . Studies by Godbole et al 89 have demonstrated that the apocynin recovers the production of nitrite and the vasodilation in ordinary femoral arteries of swines 89 . As the DIP do not stand for a specific inhibitor of the NADPH oxidase, the apocynin became very popular 6 , with 692 records of publications on the PubMed database until January 15, 2009, 571 out of which are specific for the key "apocynin NADPH oxidase inhibition", demonstrating strong correlation between the terms.
Leukocytes are capable of mediating the apocynin inhibiting effect. It may be suggested that myeloperoxidase (MPO), selectively expressed in leukocytes, is necessary for the occurrence of the inhibiting effect of this substance. In HEK293 cells with no MPO, the formation of apocynin dimers does not occur even with superexpression of Nox isoforms 6 . When human MPO is added, dimers may be identified in cells with superexpression of Nox isoforms or in cells co-incubated with H 2 O 2 . In absence of H 2 O 2 or Nox, dimer production by HEK293 cells is inhibited. In stimulated leukocytes, dimers are promptly detectable, insofar as in stimulated vascular cells, there is not such production, even in presence of MPO. Thus, the authors suggest that the apocynin would act as anti-oxidant and not as inhibitor of NADPH oxidase in non-phagocytic cells 6, 88 , and the inhibiting action for the NADPH oxidase would be restricted to leukocytes which express MPO 6 (Fig.  3) . However, peroxidases other than the MPO may influence the apocynin activity, and it is possible that vascular cells have peroxidative enzymes capable of activating this inhibitor. Such fact is confirmed by findings on endothelial cells, in which apocynin dimers were identified, inhibiting, depending on concentration, the NADPH oxidase activity, the formation of RONS and the cell proliferation 88 .
Pagano et al 90 developed the chimeric peptide gp91ds-Tat, comprised of nine amino acids of HIV protein coat and nine amino acids of gp91phox 1, 10 . This substance presents reaction with p47phox and interferes in bond of this subunit with the gp91phox. The "Tat" portion allows the gp91ds-Tat to penetrate into the cell, and, thus, it is effective inhibitor of oxidases which contain gp91phox. However, despite the peptides as the one referred to are useful in experimental interventions, biotransformation processes render its oral administration difficult, limiting its potential in clinical therapeutics 1 
.
Peptidic inhibitors of NADPH oxidase are also described, such as the antibiotic PR-39, endogenously secreted by intestine cells and neutrophils of humans and swines. They act both as immunity cells and as inhibitors to the non-phagocytic NADPH oxidase activity. Initially, the PR-39 was seen as a specific inhibitor of the NADPH oxidase. However, recent studies have shown that the antibiotic presents several effects, partly because it binds to SH3 domains of other proteins and also because it interacts with membrane lipides 5 .
Conclusion
This study identified that the NADPH oxidase emerged as one of the main structures involved in vascular redox unbalance. As the • NO is also capable of suppressing the NADPH oxidase activity, this event is believed to present direct implications not only in the development of vascular disease, but also acute recovery of ischemia and reperfusion lesion, in which NADPH-dependent unbalance is of major contribution 1, 5 .
The development of oxidase specific inhibitors, based on Nox units, may experimentally provide tools to enlighten on the role of these enzymes. It may also be useful in the treatment of several diseases 1 , mainly when it comes to selective enzyme inhibition aiming to reduce the vascular damage arising out of excessive production of RONS without, nonetheless, compromising the cell signaling mechanism which depend upon said species.
